Ticker Details
Janux Therapeutics, Inc.
IPO Date:	June 11, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.06B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.87 | 3.76%
Avg Daily Range (30 D):	$0.34 | 2.14%
Avg Daily Range (90 D):	$0.30 | 2.00%

Institutional Daily Volume
Avg Daily Volume:	.48M
Avg Daily Volume (30 D):	.56M
Avg Daily Volume (90 D):	.81M

Trade Size
Avg Trade Size (Sh.):	69
Avg Trade Size (Sh.) (30 D):	54
Avg Trade Size (Sh.) (90 D):	62

Institutional Trades
Total Institutional Trades:	1,875
Avg Institutional Trade:	$2.17M
Avg Institutional Trade (30 D):	$1.97M
Avg Institutional Trade (90 D):	$1.74M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$3.19M
Avg Closing Trade (30 D):	$2.12M
Avg Closing Trade (90 D):	$2.18M
Avg Closing Volume:	121.22K

News

Jan 22, 2026 @ 7:02 PM Janux Therapeutics Strikes Bristol Myers Biotech D... Source: Vandana Singh

Dec 4, 2024 @ 11:23 PM Why Janux Therapeutics Crushed the Market Today Source: Eric Volkman

May 30, 2024 @ 3:01 PM The Latest Analyst Ratings For Janux Therapeutics Source: Benzinga Insights

May 13, 2024 @ 1:00 PM Analyst Ratings For Janux Therapeutics Source: Benzinga Insights

May 7, 2024 @ 12:15 PM Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q1 Los... Source: Zacks Equity Research

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-1.64	$-.35	$-.39
Diluted EPS	$-1.64	$-.35	$-.39
Revenue	$24M	$10.27M	$3.73M
Gross Profit
Net Income / Loss	$-102.59M	$-21.97M	$-24.36M
Operating Income / Loss	$-143.56M	$-31.69M	$-34.21M
Cost of Revenue
Net Cash Flow	$-24.68M	$-24.06M	$-.51M
PE Ratio